• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在联合使用4-喹诺酮类药物期间人体咖啡因消除率降低。

Decrease of caffeine elimination in man during co-administration of 4-quinolones.

作者信息

Stille W, Harder S, Mieke S, Beer C, Shah P M, Frech K, Staib A H

机构信息

Zentrum der Inneren Medizin, Infektiologie, Klinikum der Johann Wolfgang Goethe-Universität Frankfurt, Federal Republic of Germany.

出版信息

J Antimicrob Chemother. 1987 Nov;20(5):729-34. doi: 10.1093/jac/20.5.729.

DOI:10.1093/jac/20.5.729
PMID:3480885
Abstract

The single dose pharmacokinetics of caffeine (220-230 mg per dose) were investigated in 12 healthy male volunteers before and during treatment with ofloxacin (200 mg bd), ciprofloxacin (250 mg bd) and enoxacin (400 mg bd) with a cross-over study design. None of the parameters: mean elimination half-life (T1/2el), Cmax, total body clearance (Cltot) and the volume of distribution (aVd) of caffeine were noticeably altered by administration of ofloxacin. Striking changes were observed, however, after administration of enoxacin: the T1/2el was prolonged by as much as 260%, the Cmax increased by 41%; the aVd was reduced by 20% and Cltot by 78% (mean values). Treatment with ciprofloxacin led to a prolongation of T1/2el by 15%, to a decrease of aVd by 25% and to a 33% decrease of Cltot. The results of this intra-individual comparison of caffeine pharmacokinetic data demonstrate that treatment with ciprofloxacin and enoxacin may have a significant inhibitory effect on caffeine elimination.

摘要

采用交叉研究设计,在12名健康男性志愿者中研究了咖啡因(每剂220 - 230毫克)的单剂量药代动力学,研究时间为服用氧氟沙星(200毫克,每日两次)、环丙沙星(250毫克,每日两次)和依诺沙星(400毫克,每日两次)之前及期间。氧氟沙星给药后,咖啡因的各项参数:平均消除半衰期(T1/2el)、Cmax、总体清除率(Cltot)和分布容积(aVd)均未出现明显改变。然而,服用依诺沙星后观察到显著变化:T1/2el延长多达260%,Cmax增加41%;aVd降低20%,Cltot降低78%(平均值)。环丙沙星治疗导致T1/2el延长15%,aVd降低25%,Cltot降低33%。咖啡因药代动力学数据的个体内比较结果表明,环丙沙星和依诺沙星治疗可能对咖啡因消除有显著抑制作用。

相似文献

1
Decrease of caffeine elimination in man during co-administration of 4-quinolones.在联合使用4-喹诺酮类药物期间人体咖啡因消除率降低。
J Antimicrob Chemother. 1987 Nov;20(5):729-34. doi: 10.1093/jac/20.5.729.
2
Interaction between quinolones and caffeine.喹诺酮类药物与咖啡因之间的相互作用。
Drugs. 1987;34 Suppl 1:170-4. doi: 10.2165/00003495-198700341-00035.
3
Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.喹诺酮类药物在志愿者体内的药代动力学:拟议的给药方案。
Rev Infect Dis. 1988 Jan-Feb;10 Suppl 1:S83-9.
4
Gyrase-inhibitors impair caffeine elimination in man.
Methods Find Exp Clin Pharmacol. 1987 Mar;9(3):193-8.
5
[In vitro activity of new quinolones against Mycoplasma pathogenic to humans].新型喹诺酮类药物对人致病性支原体的体外活性
Pathol Biol (Paris). 1988 May;36(5):496-9.
6
Ciprofloxacin-caffeine: a drug interaction established using in vivo and in vitro investigations.
Am J Med. 1989 Nov 30;87(5A):89S-91S. doi: 10.1016/0002-9343(89)90031-4.
7
4-quinolones inhibit biotransformation of caffeine.4-喹诺酮类药物抑制咖啡因的生物转化。
Eur J Clin Pharmacol. 1988;35(6):651-6. doi: 10.1007/BF00637602.
8
The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin.依诺沙星和氧氟沙星的体外活性与环丙沙星的比较。
J Antimicrob Chemother. 1985 May;15(5):551-8. doi: 10.1093/jac/15.5.551.
9
Comparative pharmacokinetics of new quinolones.新型喹诺酮类药物的比较药代动力学
Drugs. 1987;34 Suppl 1:21-5. doi: 10.2165/00003495-198700341-00006.
10
Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.茶碱维持治疗期间氧氟沙星、依诺沙星、环丙沙星和培氟沙星等喹诺酮类衍生物的稳态动力学
Drugs. 1987;34 Suppl 1:159-69. doi: 10.2165/00003495-198700341-00034.

引用本文的文献

1
Pharmacokinetics of Caffeine: A Systematic Analysis of Reported Data for Application in Metabolic Phenotyping and Liver Function Testing.咖啡因的药代动力学:对用于代谢表型分析和肝功能测试的报告数据的系统分析
Front Pharmacol. 2022 Feb 25;12:752826. doi: 10.3389/fphar.2021.752826. eCollection 2021.
2
PK-DB: pharmacokinetics database for individualized and stratified computational modeling.PK-DB:用于个体化和分层计算建模的药代动力学数据库。
Nucleic Acids Res. 2021 Jan 8;49(D1):D1358-D1364. doi: 10.1093/nar/gkaa990.
3
Quantitative Prediction of Drug Interactions Caused by CYP1A2 Inhibitors and Inducers.
CYP1A2抑制剂和诱导剂引起的药物相互作用的定量预测
Clin Pharmacokinet. 2016 Aug;55(8):977-90. doi: 10.1007/s40262-016-0371-x.
4
Clinically significant pharmacokinetic interactions between dietary caffeine and medications.饮食中的咖啡因与药物之间具有临床意义的药代动力学相互作用。
Clin Pharmacokinet. 2000 Aug;39(2):127-53. doi: 10.2165/00003088-200039020-00004.
5
In vivo and in vitro toxicodynamic analyses of new quinolone-and nonsteroidal anti-inflammatory drug-induced effects on the central nervous system.新型喹诺酮类和非甾体抗炎药对中枢神经系统影响的体内和体外毒代动力学分析
Antimicrob Agents Chemother. 1999 May;43(5):1091-7. doi: 10.1128/AAC.43.5.1091.
6
Enoxacin: a reappraisal of its clinical efficacy in the treatment of genitourinary tract infections.依诺沙星:对其治疗泌尿生殖道感染临床疗效的重新评估。
Drugs. 1996 Jan;51(1):137-60. doi: 10.2165/00003495-199651010-00009.
7
Tolerability of fluoroquinolone antibiotics. Past, present and future.氟喹诺酮类抗生素的耐受性:过去、现在与未来
Drug Saf. 1995 Dec;13(6):343-58. doi: 10.2165/00002018-199513060-00004.
8
The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomes.酶抑制对人肝微粒体中他克林代谢及活化的影响。
Br J Clin Pharmacol. 1994 Jul;38(1):15-22. doi: 10.1111/j.1365-2125.1994.tb04316.x.
9
4-quinolones inhibit biotransformation of caffeine.4-喹诺酮类药物抑制咖啡因的生物转化。
Eur J Clin Pharmacol. 1988;35(6):651-6. doi: 10.1007/BF00637602.
10
Fluoroquinolone antimicrobial agents.氟喹诺酮类抗菌剂。
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.